BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,400,000 | -17.2% | 37,111 | -3.8% | 0.01% | -8.3% |
| Q4 2021 | $5,316,000 | -8.1% | 38,577 | -7.4% | 0.01% | -20.0% |
| Q3 2021 | $5,786,000 | +41.4% | 41,654 | -1.2% | 0.02% | +50.0% |
| Q2 2021 | $4,093,000 | +32.6% | 42,154 | -6.6% | 0.01% | +11.1% |
| Q1 2021 | $3,086,000 | -17.4% | 45,153 | +3.6% | 0.01% | -10.0% |
| Q4 2020 | $3,737,000 | +29.8% | 43,603 | -1.5% | 0.01% | +11.1% |
| Q3 2020 | $2,879,000 | -13.5% | 44,282 | -2.8% | 0.01% | -18.2% |
| Q2 2020 | $3,329,000 | +107.2% | 45,536 | -3.6% | 0.01% | +57.1% |
| Q1 2020 | $1,607,000 | -39.7% | 47,244 | -3.6% | 0.01% | -22.2% |
| Q4 2019 | $2,667,000 | +27.5% | 49,002 | -2.2% | 0.01% | +12.5% |
| Q3 2019 | $2,091,000 | – | 50,107 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |